ES2127761T3 - Vacuna contra la dermatomicosis. - Google Patents

Vacuna contra la dermatomicosis.

Info

Publication number
ES2127761T3
ES2127761T3 ES92921537T ES92921537T ES2127761T3 ES 2127761 T3 ES2127761 T3 ES 2127761T3 ES 92921537 T ES92921537 T ES 92921537T ES 92921537 T ES92921537 T ES 92921537T ES 2127761 T3 ES2127761 T3 ES 2127761T3
Authority
ES
Spain
Prior art keywords
dermatomycosis
vaccine
dermatomycosis vaccine
vaccines
media
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92921537T
Other languages
English (en)
Inventor
Igor Dimitriesich Polyakov
Ludmilla Ivanova
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Vetmedica GmbH
Boehringer Ingelheim Animal Health USA Inc
Original Assignee
Boehringer Ingelheim Vetmedica GmbH
Boehringer Ingelheim Vetmedica Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21587621&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2127761(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Vetmedica GmbH, Boehringer Ingelheim Vetmedica Inc filed Critical Boehringer Ingelheim Vetmedica GmbH
Application granted granted Critical
Publication of ES2127761T3 publication Critical patent/ES2127761T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungal isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0002—Fungal antigens, e.g. Trichophyton, Aspergillus, Candida
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Hall/Mr Elements (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A LA PREPARACION DE VACUNAS Y SU APLICACION PARA LA PRODUCCION DE MEDIOS PARA LA PREVENCION ESPECIFICA Y EL TRATAMIENTO DE LA DERMATOMICOSIS.
ES92921537T 1991-10-21 1992-10-17 Vacuna contra la dermatomicosis. Expired - Lifetime ES2127761T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU915006861A RU2020959C1 (ru) 1991-10-21 1991-10-21 Вакцина поливак-тм для профилактики и лечения дерматофитозов животных

Publications (1)

Publication Number Publication Date
ES2127761T3 true ES2127761T3 (es) 1999-05-01

Family

ID=21587621

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92921537T Expired - Lifetime ES2127761T3 (es) 1991-10-21 1992-10-17 Vacuna contra la dermatomicosis.

Country Status (23)

Country Link
US (3) US6872399B2 (es)
EP (1) EP0564620B1 (es)
JP (2) JP3701304B2 (es)
KR (1) KR100262980B1 (es)
AT (1) ATE177009T1 (es)
BG (1) BG63064B2 (es)
CA (1) CA2097702C (es)
CZ (1) CZ287995B6 (es)
DE (3) DE59209641D1 (es)
DK (1) DK0564620T3 (es)
ES (1) ES2127761T3 (es)
GR (1) GR3029663T3 (es)
HK (1) HK1010682A1 (es)
HU (1) HU219263B (es)
LU (1) LU91007I2 (es)
MX (1) MX9206000A (es)
NL (1) NL300112I2 (es)
PL (1) PL175059B1 (es)
PT (1) PT100989B (es)
RU (1) RU2020959C1 (es)
SG (1) SG49872A1 (es)
SK (1) SK280570B6 (es)
WO (1) WO1993007894A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2020959C1 (ru) 1991-10-21 1994-10-15 Игорь Дмитриевич Поляков Вакцина поливак-тм для профилактики и лечения дерматофитозов животных
GB2304347A (en) 1995-08-11 1997-03-19 Boeringer Ingelheim Vetmedica Antigenic preparations
EP0834322A3 (en) 1996-10-04 1998-04-22 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Mycosis vaccine
WO2001015725A1 (en) * 1998-09-24 2001-03-08 Alpharma As Vaccine for the protection of a vertebrate animal against fungal skin infection
CZ20012732A3 (cs) * 2001-07-27 2002-08-14 Bioveta, A.S. Vakcína proti dermatofytózám a způsob její výroby
EA025263B1 (ru) * 2014-06-23 2016-12-30 Общество С Ограниченной Ответственностью "Научно-Производственный Центр Пробиотех" Разбавитель-адъювант для сухой живой вакцины против трихофитии крупного рогатого скота
ES2894370T3 (es) 2016-03-15 2022-02-14 Igor Polyakov Composiciones para el tratamiento y prevención de enfermedades podales y de las pezuñas
CN107988134B (zh) * 2018-01-19 2021-07-27 中国农业大学 一种提高芽孢杆菌产芽孢率的菌种驯化方法
RU2727766C1 (ru) * 2019-12-16 2020-07-23 Александр Юрьевич Ханис Способ изготовления инактивированной вакцины против дерматофитозов животных

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU548947A1 (ru) * 1975-09-05 1980-02-05 Всесоюзный Ордена Ленина Институт Экспериментальной Ветеринарии Васхнил Вакцина дл специфической профилактики и трерапии трихофитии лошадей
US4129647A (en) * 1977-10-17 1978-12-12 Edmund Klein Treatment of acne
NO153458C (no) * 1978-06-07 1986-03-26 Inst Experimentalnoi Veterinar Fremgangsm¨te for fremstilling av vaksine for profylakse o g behandling av ringorm hos pelsdyr og kaniner for¨rsaket av trichophyton mentagrophytes.
US4657761A (en) * 1985-06-05 1987-04-14 Pinto Cesar M Polyvalent non-specific immuno-stimulating vaccine and method
CA2011896C (en) * 1989-04-21 2001-05-08 Mark Werner Ringworm vaccine
US5284652A (en) * 1990-10-26 1994-02-08 Pier Allan C Dermatophyte vaccine
US5277904A (en) * 1990-10-26 1994-01-11 Pier Allan C Broad spectrum dermatophyte vaccine
RU2020959C1 (ru) * 1991-10-21 1994-10-15 Игорь Дмитриевич Поляков Вакцина поливак-тм для профилактики и лечения дерматофитозов животных
GB2304347A (en) * 1995-08-11 1997-03-19 Boeringer Ingelheim Vetmedica Antigenic preparations
EP0834322A3 (en) * 1996-10-04 1998-04-22 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Mycosis vaccine
CA2287451C (en) * 1997-04-18 2014-06-10 Sean Farmer Topical use of probiotic bacillus spores to prevent or control microbial infections
US6645506B1 (en) * 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
WO2001015725A1 (en) * 1998-09-24 2001-03-08 Alpharma As Vaccine for the protection of a vertebrate animal against fungal skin infection
WO2000021546A1 (fr) * 1998-10-09 2000-04-20 Mitsui Sugar Co., Ltd Prophylactiques/medicaments pour l'infection, agents anti-endotoxine, adjuvants de vaccin et promoteurs de croissance
US6436926B1 (en) * 1999-05-10 2002-08-20 Medpointe, Inc. Compositions and methods for treating superficial fungal infections
RU2192885C2 (ru) * 2001-01-30 2002-11-20 Ханис Александр Юрьевич Способ изготовления вакцины для профилактики и лечения дерматофитозов домашних и лабораторных животных

Also Published As

Publication number Publication date
JPH06506476A (ja) 1994-07-21
SK71093A3 (en) 1993-10-06
DE9218921U1 (de) 1996-02-15
PL175059B1 (pl) 1998-10-30
US20040202672A1 (en) 2004-10-14
SK280570B6 (sk) 2000-03-13
JP2005029578A (ja) 2005-02-03
DE59209641D1 (de) 1999-04-08
BG63064B2 (bg) 2001-02-28
ATE177009T1 (de) 1999-03-15
NL300112I1 (nl) 2003-04-01
CA2097702A1 (en) 1993-04-22
JP3701304B2 (ja) 2005-09-28
GR3029663T3 (en) 1999-06-30
NL300112I2 (nl) 2003-05-01
MX9206000A (es) 1993-05-01
DE19975045I2 (de) 2000-01-13
HU9301798D0 (en) 1993-10-28
CZ144893A3 (en) 1994-01-19
CA2097702C (en) 2004-08-17
US7666440B2 (en) 2010-02-23
EP0564620B1 (de) 1999-03-03
PL299982A1 (en) 1994-04-18
HU219263B (en) 2001-03-28
US7235246B2 (en) 2007-06-26
DK0564620T3 (da) 1999-09-27
RU2020959C1 (ru) 1994-10-15
KR100262980B1 (ko) 2000-08-01
PT100989B (pt) 1999-10-29
US20080075743A1 (en) 2008-03-27
PT100989A (pt) 1994-01-31
HK1010682A1 (en) 1999-06-25
EP0564620A1 (de) 1993-10-13
WO1993007894A1 (de) 1993-04-29
KR930703014A (ko) 1993-11-29
HUT68503A (en) 1995-06-28
US20020155134A1 (en) 2002-10-24
LU91007I2 (fr) 2003-03-31
CZ287995B6 (cs) 2001-03-14
US6872399B2 (en) 2005-03-29
SG49872A1 (en) 1998-06-15

Similar Documents

Publication Publication Date Title
ES2173300T3 (es) Vacunas de virus vivos prrs de baja patogenicidad y metodos para su preparacion.
ES2150933T3 (es) Inhibidores de la proteasa vih utiles para el tratamiento del sida.
ES2193337T3 (es) Utilizacion de sales de estroncio para el tratamiento de la artrosis.
HN2000000115A (es) Formulacion de sal comun y moxifloxacina
ES2186809T3 (es) Composiciones de vacunas para administracion intranasal, comprendiendo chitosana y su uso.
HN1999000124A (es) Derivados de pirazol substituido.
BR9713363A (pt) Epotilonas c, d, e e f, preparação e composições
NO307968B1 (no) Pyrazolo- og pyrrolopyridiner og farmasøytisk blanding derav
HN2001000243A (es) Inhibidores de metaloproteinasa del tipo pirimidin - 2, 4, 6 - triona
HN2001000244A (es) Inhibidores de espiropirimidin - 2, 4, 6 - triona metaloproteinasas.
ES2169147T3 (es) Derivados de beta-carbolina agonistas de la melatonina, sus procedimientos de preparacion y su utilizacion a titulo de medicamento.
ES2127761T3 (es) Vacuna contra la dermatomicosis.
DK0532595T3 (da) Farmakologisk anvendelse af visse cystinderivater
ES2191449T3 (es) Derivados de ciclopentabenzofurano y su uso.
HUP0200152A2 (hu) KQT1 csatornák gátlóinak alkalmazása parazita férgek és ektoparaziták által okozott betegségek kezelésére alkalmas gyógyszerkészítmények előállítására
YU42098A (sh) Upotreba olanzapina
ES2118248T3 (es) Esteres y amidas de 9-cloro-prostaglandina y su empleo para preparar medicamentos.
DOP2001000140A (es) Aril y heteroarilsulfonatos
AR059965A2 (es) Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante
ES2066206T3 (es) Utilizacion de adenilciclasa como vacunas contra bordetella.
HUP9900504A2 (en) Use of insect pheromones for producing pharmaceutical compositions having antiglucocorticoid effect
TW200503755A (en) Avian vaccine composition for the protection of poultry against disease and infection caused by e. coli and salmonella
ES2049280T3 (es) Utilizacion de un extracto seco de las hojas de ginkgo contra metastasis.
HUP0002377A2 (hu) Melatoninerg ligandumok alkalmazása gyomor-bélrendszeri betegségek kezelésére vagy megelőzésére alkalmas gyógyászati készítmények előállítására és a készítmények
HN2001000119A (es) S-metil-dihidro -ziprasidona para el tratamiento de trastornos psiquiatricos y oculares.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 564620

Country of ref document: ES